Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19Review Article Published on 2024-06-172024-09-05 Journal: Heliyon [Category] update2024, [키워드] COVID-19 Diagnosis pharmacological treatment SARS-CoV-2 [DOI] 10.1016/j.heliyon.2024.e33179 PMC 바로가기 [Article Type] Review Article
Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwanarticle Published on 2023-02-082024-09-02 Journal: Journal of Translational Medicine [Category] 대상포진, [키워드] Anxiety chronic fatigue syndrome Depression pharmacological treatment [DOI] 10.1186/s12967-023-03886-1 PMC 바로가기 [Article Type] article
Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trialArticle Published on 2022-11-032022-11-16 Journal: Journal of Translational Medicine [Category] 비임상, [키워드] 1:1 Administered administration adverse event age Analysis animal model Anti-inflammatory assigned baseline Borg change changes in Chronic diseases clinical trial clinically COVID COVID pneumonia COVID-19 defined Diagnosis discharged double-blind Dyspnea Effect effective Efficacy Endpoint enrolled evaluated female female gender FEV first symptom FVC impairment increase in indicated Infection initial LLC lung damage Lung fibrosis Lung function Lungs mMRC moderate NCT04527354 offer past medical history Patient patients pharmacological treatment Placebo placebo group placebo-controlled clinical trial placebo-controlled trial Post-COVID rehabilitation predicted Prevent Primary outcome proportion pulmonary dysfunction pulmonary fibrosis Pulmonary function questionnaire Randomized Randomly reduction in Registered rehabilitation risk factor Russia SARS-CoV-2 secondary shown significant decrease significant difference stratified Support Symptoms Tolerability Treamid. Treatment Trial was done women [DOI] 10.1186/s12967-022-03660-9 PMC 바로가기
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19Article Published on 2022-11-012022-11-15 Journal: European Journal of Hospital Pharmacy [Category] SARS, 진단, [키워드] 30-Day mortality Administered administration adverse event adverse events analysed Biomarker C-reactive protein clinical Clinical improvement cohorts of patient comparable complementary Complementary therapies coronavirus disease COVID-19 Critical Critical care decrease Efficacy epidemiologically group hospitalised Hypothesis inflammatory parameters knowledge lactate dehydrogenase medication Mortality onset of symptom outcome Patient patients with COVID-19 pharmacological treatment Pneumonia Primary outcome pulmonary medicine Quotient radiological radiological improvement radiology randomised controlled trial reductions in SaO_{2} secondary Severe COVID-19 pneumonia statistically significant difference subgroup subgroups the timing therapy Tocilizumab tocilizumab administration two group were recorded while [DOI] 10.1136/ejhpharm-2020-002669 PMC 바로가기
Consensus of the Liaison-Psychiatry Committee of the Colombian Psychiatric Association on the Diagnosis and Treatment of Delirium in the Context of the COVID-19 PandemicPractice guideline Published on 2022-09-012022-10-05 Journal: Revista Colombiana de Psiquiatría (English ed.) [Category] COVID19(2023년), SARS, 진단, 치료법, 치료제, [키워드] absence alteration Antipsychotics approach Brain Care caused Committee Consensus Context Coronavirus infection cough COVID-19 delirium Diagnosis diagnostic diagnostic techniques and procedures disease disorder Evidence Fever Health hospital Hospitalization increase increase in Infection interactions lung malaise Mental morbidity and mortality New coronavirus organ pandemic Patient pharmacological pharmacological treatment recommendation SARS-CoV-2 severe SARS-CoV-2 Side effect supported the patient Treatment treatments [DOI] 10.1016/j.rcpeng.2020.11.008 [Article Type] Practice guideline
Connecting the dots between inflammatory cascades of obesity and COVID-19 in light of mortal consequences-a review치명적인 결과에 비추어 비만의 염증성 폭포와 COVID-19 사이의 점 연결 - 리뷰Review Published on 2022-08-012022-09-12 Journal: Environmental science and pollution research inter [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] ACE2 adipocyte adverse effects age angiotensin-converting enzyme 2 BMI body mass index cardiometabolic cascade children Coagulation combating complications consequence coronavirus disease correlation country COVID-19 Cytokine storm D-dimer determinant endothelial Epidemics Factors fatal disease greater immunological implicated individual individuals Inflammatory inflammatory cascade inflammatory parameters inflammatory pathology intensive care less Major molecular obese obesity organization pathology pathophysiological PBM pharmacological treatment RAAS reported resource risk Stress suggested therapeutic options therapy Treatment triggering vessel WAT. [DOI] 10.1007/s11356-022-21461-x PMC 바로가기 [Article Type] Review
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits Reviews Published on 2022-07-282022-10-05 Journal: Nature Reviews Endocrinology [Category] 유전자 메커니즘, 진단, [키워드] affected arising benefit caused childhood complex defined disease driven by early-onset effect sizes environmental factors example Features form Genetic Genetic predisposition Genetic testing hyperphagia infancy Interaction involved knowledge MOST multifactorial obesity pathogenic variant pathway Patient patients with obesity pharmacological treatment Regulation regulatory circuit single gene syndrome therapy Treatment treatment approach variant [DOI] 10.1038/s41574-022-00716-0 [Article Type] Reviews
Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival중증 급성 호흡기 증후군으로 입원한 COVID-19 환자: 임상 결과, 약리학적 치료 및 생존을 평가하기 위한 인구 기반 레지스트리 분석Article Published on 2022-06-192022-09-12 Journal: Medicina [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome age Antibiotics antimalarial carried clinical Clinical findings Clinical outcome Corticosteroid COVID-19 COVID-19 patient death develop Disseminated intravascular coagulation females hospital hospitalized patient In-hospital incidence male material Medicine Mortality mortality rate Older Patient patients with SARS pharmacological pharmacological treatment predictor predictors Prevalence Probability real-world data registry respiratory SARS-CoV-2 Severe acute respiratory syndrome steroid survival treatment for COVID-19 variable Ventilation with COVID-19 [DOI] 10.3390/medicina58060829 PMC 바로가기 [Article Type] Article
The Extracts of Polygonum cuspidatum Root and Rhizome Block the Entry of SARS-CoV-2 Wild-Type and Omicron Pseudotyped Viruses via Inhibition of the S-Protein and 3CL ProteasePolygonum cuspidatum 뿌리 및 뿌리 줄기 추출물은 S-단백질 및 3CL 프로테아제의 억제를 통해 SARS-CoV-2 야생형 및 오미크론 의사형 바이러스의 진입을 차단합니다Article Published on 2022-06-132022-09-11 Journal: Molecules [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] 3CL ACE2 angiotensin Angiotensin-converting enzyme Anti-viral block blocked caused Chinese Compound contagious COVID-19 develop disease effective Efficacy Ethanol Extract fibroblast fibroblasts gallic acid herbal medicine Infection inhibit inhibition Interaction omicron Omicron variant pandemic pharmacological treatment phytochemical Polygoni Cuspidati Rhizoma et Radix Polygonum Protease activity Pseudotyped virus pseudovirus pseudovirus entry Radix receptor responsible resulting rhizome root S-protein SARS-CoV-2 SARS-CoV-2 pseudotyped virus SARS-CoV-2 virus shown Spike protein tested the SARS-CoV-2 the SARS-CoV-2 virus the spike protein Traditional Chinese medicine Treatment Vaccines water wild-type zebrafish zebrafish larvae. [DOI] 10.3390/molecules27123806 PMC 바로가기 [Article Type] Article
Pregnancy and COVID-19, focus on vaccine and pharmacological treatment임신과 코로나19, 백신과 약리치료에 집중Review Published on 2022-06-012022-09-11 Journal: Journal of reproductive immunology [Category] 변종, 임상, 치료법, 치료제, [키워드] change clinical clinical evidence clinical trials Comorbidities compassionate use Complication complications COVID-19 COVID-19 disease COVID-19 mRNA vaccine COVID-19 mRNA vaccines drug treatments drugs during pregnancy Evidence excluded global pandemic group highlighting immune increased risk indicate individual Infants Infection knowledge limit mother off-label pharmacological treatment population groups Pregnancy pregnancy complications pregnant women progression recommendation Respiratory system Spread therapy vaccination Vaccine variant variants virus women [DOI] 10.1016/j.jri.2022.103630 PMC 바로가기 [Article Type] Review